|
| Press Releases |
|
 |
|
| Thursday, August 20, 2020 |
|
|
汇景控股2020年中期业绩 纯利大幅上升43.4% |
| 立足大湾区的中国综合住宅及商用物业开发商汇景控股有限公司（「汇景控股」或「集团」﹔股份代号﹕9968）公布于2020年1月16日在香港联合交易所有限公司（「联交所」）主板上市后首个中期业绩。 more info >> |
|
|
滙景控股2020年中期業績 純利大幅上升43.4% |
| 立足大灣區的中國綜合住宅及商用物業開發商滙景控股有限公司（「滙景控股」或「集團」﹔股份代號﹕9968）公佈於2020年1月16日在香港聯合交易所有限公司（「聯交所」）主板上市後首個中期業績。 more info >> |
|
|
Huijing Holdings 2020 Interim Results, Net Profit Increases Significantly by 43.4% |
Huijing Holdings Company Limited ("Huijing Holdings" or the "Group"; Stock code: 9968 ), an integrated residential and commercial property developer in the People's Republic of China ("PRC"), with a foothold in the Greater Bay Area, has announced its first interim results for the period ended 30 June 2020 ("1H2020" or "the Period") since listing on the Main Board of The Stock Exchange of Hong Kong Limited ("HKEX") on 16 January 2020.
more info >> |
|
| Thursday, August 13, 2020 |
|
|
汇景控股有限公司公布正面盈利预告 |
| 立足大湾区的中国综合住宅及商用物业开发商汇景控股有限公司（「汇景控股」或「集团」﹔股份代号﹕9968）今天欣然公告，预计截至二零二零年六月三十日止六个月 (「报告期间」)，集团溢利较去年同期相比大幅增加最少40%，表现理想。 more info >> |
|
|
滙景控股有限公司公佈正面盈利預告 |
| 立足大灣區的中國綜合住宅及商用物業開發商滙景控股有限公司（「滙景控股」或「集團」﹔股份代號﹕9968）今天欣然公告，預計截至二零二零年六月三十日止六個月 (「報告期間」)，集團溢利較去年同期相比大幅增加最少40%，表現理想。 more info >> |
|
|
Huijing Holdings Limited Announces Positive Profit Alert for 2020 Interim |
| Huijing Holdings Company Limited ("Huijing Holdings" or the "Group"; Stock code: 9968), an integrated residential and commercial property developer in the PRC with a foothold in the Greater Bay Area, has today announced that it expects to record a period-on-period increase in net profit of not less than 40% for the six months ended 30 June 2020 (the "Reporting Period"). more info >> |
|
| Wednesday, May 13, 2020 |
|
|
汇景控股获纳入明晟（MSCI）中国全股票小型股指数 |
| 立足大湾区的中国综合住宅及商用物业开发商汇景控股有限公司（「汇景控股」或「集团」﹔股份代号﹕9968）欣然公布，集团获纳入明晟（MSCI）中国全股票小型股指数，并于2020年5月29日收市后正式生效。 more info >> |
|
|
滙景控股獲納入明晟（MSCI）中國全股票小型股指數 |
| 立足大灣區的中國綜合住宅及商用物業開發商滙景控股有限公司（「滙景控股」或「集團」﹔股份代號﹕9968）欣然公佈，集團獲納入明晟（MSCI）中國全股票小型股指數，並於2020年5月29日收市後正式生效。 more info >> |
|
|
Huijing Holdings Selected for Inclusion in MSCI China All Shares Small Cap Index |
| Huijing Holdings Company Limited ("Huijing Holdings" or the "Group"; Stock code: 9968), an integrated residential and commercial property developer in the PRC, with a foothold in the Greater Bay Area, has announced that the Group will be included as a constituent of the MSCI China All Shares Small Cap Index effective after the market close on 29 May 2020. more info >> |
|
| Friday, March 27, 2020 |
|
|
汇景控股有限公司公布上市后的首份全年业绩 |
立足大湾区的中国综合住宅及商用物业开发商汇景控股有限公司（「汇景控股」或「集团」﹔股份代号﹕9968）公布截至2019年12月31日止的全年业绩（「2019财年」或「年内」），为集团于2020年1月16日在香港联合交易所有限公司（「联交所」）主板上市后的首次全年业绩。
more info >> |
|
|
|
|
|
|
|
|
|
| Latest Press Releases |
|
OSL Lists State-Supervised Gold-Backed Stablecoin USDKG as Platform Expands Asia's Digital Asset Ecosystem
May 22, 2026 23:30: JST
|
|
|
OSL Lists State-Supervised Gold-Backed Stablecoin USDKG as Platform Expands Asia's Digital Asset Ecosystem
May 22, 2026 22:30 HKT/SGT
|
|
|
Six Factors to Consider When Opting for a Credit Line in Singapore
May 22, 2026 19:05 HKT/SGT
|
|
|
Patents Build Solid Barriers, Technologies Achieve All-Round Breakthroughs, New Vision Leads the New Track of AR Interaction
May 22, 2026 18:46: JST
|
|
|
Patents Build Solid Barriers, Technologies Achieve All-Round Breakthroughs, New Vision Leads the New Track of AR Interaction
May 22, 2026 17:46 HKT/SGT
|
|
|
天辰生物通過聆訊：深耕過敏與自身免疫領域 臨床療效全面領先
May 22, 2026 16:32 HKT/SGT
|
|
|
天辰生物通过聆讯：深耕过敏与自身免疫领域 临床疗效全面领先
May 22, 2026 16:32 HKT/SGT
|
|
|
Everest Medicines Receives Shareholding Increase from Substantial Shareholder CBC Group, Global Expansion Expected to Benefit
May 22, 2026 11:05: JST
|
|
|
雲頂新耀獲主要股東康橋資本增持 全球化佈局有望持續受益
May 22, 2026 10:59 HKT/SGT
|
|
|
GTJAI Won Two Awards at HR Asia 2026
May 22, 2026 10:49 HKT/SGT
|
|
|
國泰君安國際斬獲HR Asia 2026年度兩項大獎
May 22, 2026 10:49 HKT/SGT
|
|
|
国泰君安国际斩获HR Asia 2026年度两项大奖
May 22, 2026 10:49 HKT/SGT
|
|
|
Everest Medicines Receives Shareholding Increase from Substantial Shareholder CBC Group, Global Expansion Expected to Benefit
May 22, 2026 10:05 HKT/SGT
|
|
|
云顶新耀获主要股东康桥资本增持 全球化布局有望持续受益
May 22, 2026 10:05 HKT/SGT
|
|
|
Eisai Deepens Body of Clinical Evidence for LENVIMA(R) (Lenvatinib) Across Established Indications at ASCO 2026
May 22, 2026 0:23 JST
|
|
|
|
|
More News >> |
|
|
|
|
|
